Increased transforming growth factor-β1 modulates glutamate receptor expression in the hippocampus

International Journal of Physiology, Pathophysiology and Pharmacology

Volumn 3, Issue 1, 2011, Pages 9-20

  Bae, James J ^b,c,e   Xiang, Yun Yan ^a,b   Martinez Canabal, Alonso ^c,d   Frankland, Paul W ^c,d   Yang, Burton B ^e   Lu, Wei Yang ^a,b  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

^e SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

Astrocytes; Cytokine; Glutamate receptor; Microglia; Neurodegeneration

Indexed keywords

AMPA RECEPTOR; GLUTAMATE RECEPTOR; GLUTAMIC ACID; IONOTROPIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GLIOSIS; HIPPOCAMPUS; MOUSE; NERVE CELL; NERVE CELL CULTURE; NERVE CELL GROWTH; NEURITE; NONHUMAN; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

EID: 79954487229     PISSN: None     EISSN: 19448171     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Krieglstein K, Strelau J, Schober A, Sullivan A, and Unsicker K. TGF-beta and the regulation of neuron survival and death. J Physiol Paris 2002; 96(1-2): 25-30.
2. Brionne TC, Tesseur I, Masliah E, and Wyss-Coray T. Loss of TGF-beta 1 leads to increased neuronal cell death and microgliosis in mouse brain. Neuron 2003; 40(6): 1133-1145.
3. Bottner M, Krieglstein K, and Unsicker K. The transforming growth factor-betas: structure, signaling, and roles in nervous system development and functions. J Neurochem 2000; 75(6): 2227-2240.
4. Siegenthaler JA and Miller MW. Transforming growth factor beta1 modulates cell migration in rat cortex: effects of ethanol. Cereb Cortex 2004; 14(7): 791-802.
5. Gomes FC, Sousa VO, and Romao L. Emerging roles for TGF-beta1 in nervous system development. Int J Dev Neurosci 2005; 23(5): 413-424.
6. Lesne S, Blanchet S, Docagne F, Liot G, Plawinski L, MacKenzie ET, Auffray C, Buisson A, Pietu G, and Vivien D. Transforming growth factorbeta1-modulated cerebral gene expression. J Cereb Blood Flow Metab 2002; 22(9): 1114-1123.
7. Finch CE, Laping NJ, Morgan TE, Nichols NR, and Pasinetti GM. TGF-beta 1 is an organizer of responses to neurodegeneration. J Cell Biochem 1993; 53(4): 314-322.
8. Flanders KC, Ren RF, and Lippa CF. Transforming growth factor-betas in neurodegenerative disease. Prog Neurobiol 1998; 54(1): 71-85.
9. Buckwalter MS and Wyss-Coray T. Modelling neuroinflammatory phenotypes in vivo. J Neuroinflammation 2004; 1(1): 10
10. Lau CG and Zukin RS. NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders. Nat Rev Neurosci 2007; 8(6): 413-426.
11. Pellegrini-Giampietro DE, Zukin RS, Bennett MV, Cho S, and Pulsinelli WA. Switch in glutamate receptor subunit gene expression in CA1 subfield of hippocampus following global ischemia in rats. Proc Natl Acad Sci U S A 1992; 89(21): 10499-10503.
12. Kwak S and Weiss JH. Calcium-permeable AMPA channels in neurodegenerative disease and ischemia. Curr Opin Neurobiol 2006; 16(3): 281-287.
13. Beattie EC, Stellwagen D, Morishita W, Bresnahan JC, Ha BK, von Zastrow M, Beattie MS, and Malenka RC. Control of synaptic strength by glial TNFalpha. Science 2002; 295(5563): 2282-2285.
14. Stellwagen D and Malenka RC. Synaptic scaling mediated by glial TNF-alpha. Nature 2006; 440 (7087): 1054-1059.
15. Lai AY, Swayze RD, El-Husseini A, and Song C. Interleukin-1 beta modulates AMPA receptor expression and phosphorylation in hippocampal neurons. J Neuroimmunol 2006; 175(1-2): 97-106.
16. Docagne F, Nicole O, Gabriel C, Fernandez-Monreal M, Lesne S, Ali C, Plawinski L, Carmeliet P, MacKenzie ET, Buisson A, and Vivien D. Smad3-dependent induction of plasminogen activator inhibitor-1 in astrocytes mediates neuroprotective activity of transforming growth factor-beta 1 against NMDA-induced necrosis. Mol Cell Neurosci 2002; 21(4): 634-644.
17. Buisson A, Lesne S, Docagne F, Ali C, Nicole O, MacKenzie ET, and Vivien D. Transforming growth factor-beta and ischemic brain injury. Cell Mol Neurobiol 2003; 23(4-5): 539-550.
18. Wyss-Coray T, Feng L, Masliah E, Ruppe MD, Lee HS, Toggas SM, Rockenstein EM, and Mucke L. Increased central nervous system production of extracellular matrix components and development of hydrocephalus in transgenic mice overexpressing transforming growth factorbeta 1. Am J Pathol 1995; 147(1): 53-67.
19. Wyss-Coray T, Borrow P, Brooker MJ, and Mucke L. Astroglial overproduction of TGF-beta 1 enhances inflammatory central nervous system disease in transgenic mice. J Neuroimmunol 1997; 77(1): 45-50.
20. Wyss-Coray T, Masliah E, Mallory M, McConlogue L, Johnson-Wood K, Lin C, and Mucke L. Amyloidogenic role of cytokine TGFbeta1 in transgenic mice and in Alzheimer's disease. Nature 1997; 389(6651): 603-606.
21. Wyss-Coray T, Lin C, Yan F, Yu GQ, Rohde M, McConlogue L, Masliah E, and Mucke L. TGFbeta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice. Nat Med 2001; 7(5): 612-618.
22. Dong H, Xiang YY, Farchi N, Ju W, Wu Y, Chen L, Wang Y, Hochner B, Yang B, Soreq H, and Lu WY. Excessive expression of acetylcholinesterase impairs glutamatergic synaptogenesis in hippocampal neurons. J Neurosci 2004; 24(41): 8950-8960.
23. Reilly JF, Maher PA, and Kumari VG. Regulation of astrocyte GFAP expression by TGF-beta1 and FGF-2. Glia 1998; 22(2): 202-210.
24. Wakselman S, Bechade C, Roumier A, Bernard D, Triller A, and Bessis A. Developmental neuronal death in hippocampus requires the microglial CD11b integrin and DAP12 immunoreceptor. J Neurosci 2008; 28(32): 8138-8143.
25. Rotshenker S. The role of Galectin-3/MAC-2 in the activation of the innate-immune function of phagocytosis in microglia in injury and disease. J Mol Neurosci 2009; 39(1-2): 99-103.
26. Isaac JT, Ashby M, and McBain CJ. The role of the GluR2 subunit in AMPA receptor function and synaptic plasticity. Neuron 2007; 54(6): 859-871.
27. Stephenson FA. Subunit characterization of NMDA receptors. Curr Drug Targets 2001; 2(3): 233-239.
28. Smith GM and Hale JH. Macrophage/Microglia regulation of astrocytic tenascin: synergistic action of transforming growth factor-beta and basic fibroblast growth factor. J Neurosci 1997; 17(24): 9624-9633.
29. Platt SR. The role of glutamate in central nervous system health and disease--a review. Vet J 2007; 173(2): 278-286.
30. Meldrum BS. Glutamate as a neurotransmitter in the brain: review of physiology and pathology. J Nutr 2000; 130(4S Suppl): 1007S-1015S.
31. Fiala M, Cribbs DH, Rosenthal M, and Bernard G. Phagocytosis of amyloid-beta and inflammation: two faces of innate immunity in Alzheimer's disease. J Alzheimers Dis 2007; 11(4): 457-463.
32. Boche D, Cunningham C, Gauldie J, and Perry VH. Transforming growth factor-beta 1-mediated neuroprotection against excitotoxic injury in vivo. J Cereb Blood Flow Metab 2003; 23(10): 1174-1182.
33. Boche D, Cunningham C, Docagne F, Scott H, and Perry VH. TGFbeta1 regulates the inflammatory response during chronic neurodegeneration. Neurobiol Dis 2006; 22(3): 638-650.
34. Palmada M and Centelles JJ. Excitatory amino acid neurotransmission. Pathways for metabolism, storage and reuptake of glutamate in brain. Front Biosci 1998; 3: d701-d718.
35. Groc L, Bard L, and Choquet D. Surface trafficking of N-methyl-D-aspartate receptors: physiological and pathological perspectives. Neuroscience 2009; 158(1): 4-18.
36. Molnar E, Pickard L, and Duckworth JK. Developmental changes in ionotropic glutamate receptors: lessons from hippocampal synapses. Neuroscientist 2002; 8(2): 143-153.
37. Bernard V and Bolam JP. Subcellular and subsynaptic distribution of the NR1 subunit of the NMDA receptor in the neostriatum and globus pallidus of the rat: co-localization at synapses with the GluR2/3 subunit of the AMPA receptor. Eur J Neurosci 1998; 10(12): 3721-3736.
38. Nusser Z. AMPA and NMDA receptors: similarities and differences in their synaptic distribution. Curr Opin Neurobiol 2000; 10(3): 337-341.
39. Geiger JR, Melcher T, Koh DS, Sakmann B, Seeburg PH, Jonas P, and Monyer H. Relative abundance of subunit mRNAs determines gating and Ca2+ permeability of AMPA receptors in principal neurons and interneurons in rat CNS. Neuron 1995; 15(1): 193-204.
40. Sans N, Vissel B, Petralia RS, Wang YX, Chang K, Royle GA, Wang CY, O'Gorman S, Heinemann SF, and Wenthold RJ. Aberrant formation of glutamate receptor complexes in hippocampal neurons of mice lacking the GluR2 AMPA receptor subunit. J Neurosci 2003; 23(28): 9367-9373.
41. Ozawa S, Kamiya H, and Tsuzuki K. Glutamate receptors in the mammalian central nervous system. Prog Neurobiol 1998; 54(5): 581-618.
42. Gomes AR, Correia SS, Esteban JA, Duarte CB, and Carvalho AL. PKC anchoring to GluR4 AMPA receptor subunit modulates PKC-driven receptor phosphorylation and surface expression. Traffic 2007; 8(3): 259-269.
43. McKenna MC. The glutamate-glutamine cycle is not stoichiometric: fates of glutamate in brain. J Neurosci Res 2007; 85(15): 3347-3358.
44. Evanko DS, Zhang Q, Zorec R, and Haydon PG. Defining pathways of loss and secretion of chemical messengers from astrocytes. Glia 2004; 47(3): 233-240.
45. Brown DR. Dependence of neurones on astrocytes in a coculture system renders neurones sensitive to transforming growth factor beta1-induced glutamate toxicity. J Neurochem 1999; 72(3): 943-953.
46. Seifert G and Steinhauser C. Ionotropic glutamate receptors in astrocytes. Prog Brain Res 2001; 132: 287-299.
47. Konig HG, Kogel D, Rami A, and Prehn JH. TGF-{beta}1 activates two distinct type I receptors in neurons: implications for neuronal NF-{kappa}B signaling. J Cell Biol 2005; 168(7): 1077-1086.
48. Chin J, Angers A, Cleary LJ, Eskin A, and Byrne JH. TGF-beta1 in Aplysia: role in long-term changes in the excitability of sensory neurons and distribution of TbetaR-II-like immunoreactivity. Learn Mem 1999; 6(3): 317-330.
49. Zhang F, Endo S, Cleary LJ, Eskin A, and Byrne JH. Role of transforming growth factor-beta in long-term synaptic facilitation in Aplysia. Science 1997; 275(5304): 1318-1320.
50. Mishra OP, Fritz KI, and ivoria-Papadopoulos M. NMDA receptor and neonatal hypoxic brain injury. Ment Retard Dev Disabil Res Rev 2001; 7 (4): 249-253.
51. Hardingham GE. Coupling of the NMDA receptor to neuroprotective and neurodestructive events. Biochem Soc Trans 2009; 37(Pt 6): 1147-1160.
52. Schulz JB, Matthews RT, Klockgether T, Dichgans J, and Beal MF. The role of mitochondrial dysfunction and neuronal nitric oxide in animal models of neurodegenerative diseases. Mol Cell Biochem 1997; 174(1-2): 193-197.